CON-CRÉT Creatine HCl

Creatine is nitrogenous organic acid which naturally occurs in vertebrates and helps to supply energy to muscle and all cells of the body.  It’s a compound that’s involved in the formation of adenosine triphosphate (ATP) – the body’s universal energy molecule.  Creatine is made in the liver of the human body but is produced to fulfill only approximately half of the daily creatine required by the body.  It is biosynthesized from three different amino acids – arginine, glycine, and methionine. The balance of required creatine is taken in by nutritional food sources in the daily diet, mainly from meat (although much of it is destroyed by cooking).  Approximately 95% of the body’s creatine ends up being stored in the skeletal muscles, and the remaining 5% is found in brain, heart, testes, inner ear, hair cells and other organs and cells.  Once it’s used in the formation of ATP, creatine is converted to creatinine and is excreted by the body. 

Why Creatine HCl?

CON-CRĒT® Patented Creatine HCl is the #1 bioavailable creatine with 59X greater solubility and 70% greater plasma uptake than standard creatine (see below).  Backed by 8 US Patents, CON-CRĒT® is also the only micro-dosing creatine and is thereby able to avoid any of the unpleasant side effects normally caused by other forms of creatine. Because CON-CRĒT® is concentrated creatine, there is no bloating, water retention, cramping or other digestive issues when used as directed. 

CON-CRĒT® has proven to be the most soluble and potent creatine on the market and was proven in multiple academic studies to be at least 59X more soluble* than creatine monohydrate.  This is significant because creatines vary in performance largely based on solubility. And the reason solubility is crucial is that when you increase creatine solubility (the ability to dissolve), you enhance creatine delivery (absorption into body and ultimately into the muscles). 

Based on results of both animal and human studies, creatine represents a promising nutritional supplement for increasing resilience to and treating TBI. Taken together, the results of the studies presented indicate that the neuroprotection resulting from intake of creatine-supplemented diets is due, at least in part, to a suppression of secondary brain injury. Although more research is needed in both animal and human populations, these findings suggest that prophylactic creatine treatment could be useful for people with an elevated potential to incur TBI; however, there are a number of issues that need to be addressed prior to initiating creatine use in military populations.

• less time to fall asleep